The award ceremony will take place on August 13, official said, adding that the award comprises a cash prize of Rs one lakh and a memento.
The first batch of Sputnik vaccine is expected to be produced at SII's facilities in September, RDIF said in a statement.
Serum Institute of India (SII) has requested the government to take up the matter of inclusion of Covishield vaccine in the EU Vaccination Passport with the European Union and other countries, citing...
The first batch of Covovax, a COVID-19 vaccine developed by Novavax Inc, is being manufactured at the Serum Institute of India’s Pune facility, SII CEO Adar Poonawalla said on Friday.
The Centre had on May 13 approved extending the gap between the two doses of the Covishield vaccine from six to eight weeks to 12-16 weeks following a recommendation from the National Technical...
SII is likely to introduce the Novavax vaccine, to be known as Covavax in the country, by September.
The Centre on May 13 had approved extending the gap between the two doses of the Covishield vaccine from six to eight weeks to 12 to 16 weeks following a recommendation from the National Technical...
US-based biotechnology company Novavax's protein-based vaccine has shown overall 90 per cent efficacy against Covid-19, results of Phase-3 trials have shown.
The Pune-based firm has also sought approval for test analysis and examination.
In a recent letter to Union Home Minister Amit Shah, SII said its employees have been working round the clock in spite of various challenges because of the pandemic.